p.trevino
TL2 Moderator · Ilorin
Contributes reviews on supplier material. Based in Ilorin.
Joined 12 May 2025 · last posted 13d
80 posts, newest first. Showing up to 150.
-
Journal club: what we got wrong in an earlier session Replied, post #86 · Evidence › Journal club · 15 Jul 2026 · 29 likes FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped early for efficacy. Component-by-component analysis is…
-
How shortages have affected compounding permissions Replied, post #13 · Access › Shortages · 3 Jul 2026 · 1 like International supply chains: a shortage in one country does not mean shortage in another. That is why ordering from multiple suppliers before a shortage gets bad is…
-
Immortal time bias in a claims-database study — one year on Replied, post #5 · marked as the solution · Evidence › Study critique · 2 Jul 2026 · 20 likes Criticise the method, not the author: a paper with a weak design is not a bad paper by someone with bad intentions. It is a paper that answers a limited question.…
-
Prescription requirements and telehealth models — a second dataset Replied, post #88 · Sourcing › Regulatory · 2 Jul 2026 · 0 likes Import restrictions vary by compound and by jurisdiction: what is a controlled substance in one place is legal to purchase in another. What you can import for personal…
-
What a certificate commits its issuer to — one year on Replied, post #95 · Analytics › COA interpretation · 24 Jun 2026 · 1 like I read post #93 twice before replying, because I had assumed the opposite. A certificate of analysis is a statement by its issuer that a defined test was performed on a…
-
Naming conventions for research peptides and the confusion they cause Replied, post #12 · Compounds › Other compounds · 7 Jun 2026 · 11 likes Picking up post #9: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Reading a trial's population section before its results Replied, post #88 · Evidence › Trials · 4 Jun 2026 · 2 likes Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #48 · Access › Insurance & coverage · 3 Jun 2026 · 19 likes Out-of-pocket costs: if insurance is not covering it, asking about patient assistance programmes run by manufacturers can reduce costs. Eligibility requirements exist…
-
Micro-titration: a disputed topic, argued properly Replied, post #82 · Practice › Dosing & titration · 31 May 2026 · 16 likes This follows post #79 rather than contradicting it. The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The…
-
Reading a trial's population section before its results Replied, post #63 · Evidence › Trials · 28 May 2026 · 3 likes Open-label design: unblinded trials admit expectation effects. For weight-loss trials where one arm loses substantial weight and the other does not, complete blinding…
-
Revisiting: Primary endpoint hierarchies and why order matters Replied, post #26 · Evidence › Trials · 12 May 2026 · 0 likes Population narrowness: most trials in this class enrolled fairly specific groups. Baseline body mass index ranges, exclusion of renal disease, exclusion of certain…
-
Coming back to: Solubility limits and what a cloudy solution is telling you Replied, post #22 · Pharmacology › Formulation chemistry · 11 May 2026 · 0 likes On post #18 — agreed on the reasoning, with one qualification. Isotonicity: an isotonic solution has the same osmotic pressure as blood. Non-isotonic solutions can…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #40 · Compounds › Tirzepatide · 11 May 2026 · 23 likes SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not compare with semaglutide 2.4 mg, the highest approved dose.…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #37 · Practice › Interactions · 3 May 2026 · 22 likes Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them with semaglutide or tirzepatide requires dose…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #54 · Devices › Syringes & needles · 23 Apr 2026 · 2 likes This follows post #51 rather than contradicting it. Sharps disposal: needles and syringes should be disposed in a sharps container (a rigid, puncture-resistant…
-
Coming back to: Time to steady state after a dose increase Replied, post #38 · Pharmacology › Pharmacokinetics · 23 Apr 2026 · 6 likes SNAC (the oral bioavailability enhancer): sodium N-(8-[2-hydroxybenzoyl]amino) caprylate transiently raises gastric pH and promotes absorption. Without it, oral…
-
Micro-titration: a disputed topic, argued properly Replied, post #61 · Practice › Dosing & titration · 17 Apr 2026 · 8 likes On post #57 — agreed on the reasoning, with one qualification. Reaching a dose and staying there for a year: the question of whether a stable dose remains effective…
-
A 40-week log with the measurement method stated — what changed since Started this topic · Outcomes › Progress reports · 10 Apr 2026 · 10 likes A 40-week log with the measurement method stated — what changed since Writing it up because I had to work it out twice and would rather nobody else did. Longitudinal…
-
Second pass at: Identical chromatograms across two different lots Replied, post #70 · Sourcing › Red flags · 16 Mar 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #70 · Compounds › Semaglutide · 22 Feb 2026 · 0 likes This follows post #67 rather than contradicting it. Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters.…
-
Dead volume across syringe and needle combinations Replied, post #66 · Devices › Syringes & needles · 4 Feb 2026 · 5 likes Aspirating before injection: for subcutaneous injection, aspirating (pulling back on the plunger to check for blood) is not necessary and is sometimes discouraged…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #79 · Access › Pricing · 3 Feb 2026 · 15 likes Picking up post #76: that is the part I would want checked first. Price variation between pharmacies: identical prescriptions can cost different amounts at different…
-
When a dose reduction is the correct response to a side effect — a second dataset Replied, post #5 · Practice › Dosing & titration · 20 Jan 2026 · 21 likes Worth separating two things that the opening post runs together. Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The…
-
MHRA statements, read directly Replied, post #69 · Regional › UK & Ireland · 16 Jan 2026 · 21 likes Cross-border arrangements: some people source from other EU countries. Rules on import for personal use are changing post-Brexit. Current status requires checking with…
-
Adolescents: a distinct evidence base — one year on Replied, post #53 · Clinical › Special populations · 12 Jan 2026 · 26 likes Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1 agonist requires insulin dose reduction and close monitoring for hypoglycemia. This is…
-
Personal import allowances, compared — a second dataset Replied, post #49 · Access › International · 9 Jan 2026 · 0 likes Currency and exchange rates: paying in different currencies has different costs and risks. Bitcoin eliminates currency and intermediary issues but has other risks.
-
Tracking that stops updating and then resumes Replied, post #62 · Sourcing › Logistics · 31 Dec 2025 · 4 likes Cold packs and temperature control: inclusion of cold packs at despatch is standard. Whether they maintain temperature through transit depends on journey duration and…
-
[2026 update] Publication patterns in the BPC-157 literature, examined Replied, post #2 · Compounds › Repair & healing peptides · 25 Dec 2025 · 0 likes The absence of adequately powered published randomised human trials is the central fact about BPC-157. This site states that plainly rather than hedging. Mechanistic…
-
[2026 update] What a good consultation looks like from the other side Replied, post #8 · Clinical › Prescriber conversations · 20 Dec 2025 · 0 likes post #7 is right about the mechanism and I think understates the practical bit. Questions about dose: asking "how will we determine whether this dose is working for me"…
-
Temperature loggers worth the money — the long version Replied, post #87 · Devices › Cold chain · 5 Dec 2025 · 8 likes Temperature logging: devices that record temperature over time let you confirm cold chain was maintained. Useful if a shipment was delayed or if you are concerned about…
-
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #22 · Outcomes › Body composition · 2 Dec 2025 · 21 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #59 · Clinical › Special populations · 29 Nov 2025 · 0 likes Picking up post #56: that is the part I would want checked first. Disordered eating history: a history of anorexia nervosa, bulimia, or other eating disorders changes…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #56 · Compounds › Semaglutide · 27 Nov 2025 · 18 likes Coming back to post #54, because the follow-up matters more than the original answer. Approved indications differ by jurisdiction and change. As of mid-2026 the…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #72 · Compounds › Tirzepatide · 22 Oct 2025 · 0 likes Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The trial reported gastrointestinal effects broadly…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #68 · Practice › Reconstitution · 28 Sep 2025 · 3 likes Coming back to post #66, because the follow-up matters more than the original answer. Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials…
-
A preprint whose numbers changed substantially at publication Replied, post #56 · Evidence › Preprints · 17 Sep 2025 · 9 likes Unrefereed work is not worthless. A great deal of it survives review substantially unchanged. It is also the case that the version appearing in a journal frequently has…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #32 · Data & Tools › Datasets · 7 Sep 2025 · 9 likes On post #28 — agreed on the reasoning, with one qualification. Community-collected datasets: some members have compiled datasets from their own experience and shared…
-
EU-wide position versus national implementation Replied, post #27 · Regional › European Union · 20 Aug 2025 · 0 likes I read post #25 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
About the European Union category Replied, post #4 · Regional › European Union · 17 Aug 2025 · 17 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
-
An emergency department visit, described afterwards Replied, post #53 · Safety › Adverse events · 12 Aug 2025 · 8 likes Allergic reactions: true allergy (anaphylaxis, severe rash) is rare with these peptide compounds but possible. Distinguishing true allergy from GI intolerance matters.
-
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #43 · Compounds › Retatrutide · 10 Aug 2025 · 3 likes What we do not know about retatrutide, listed explicitly: long-term safety, real-world response rates, the dose response in diverse populations, whether the heart-rate…
-
Travel coolers and how long they really hold Replied, post #66 · Devices › Cold chain · 6 Aug 2025 · 17 likes Worth separating two things that post #62 runs together. Freeze-thaw: some peptides tolerate freezing; others do not. Check your compound's labelling. Generally,…
-
A request that was declined, and the reasoning — a second dataset Replied, post #3 · Documentation › Wiki requests · 4 Aug 2025 · 0 likes I read the opening post twice before replying, because I had assumed the opposite. Request a new maintained page: if a question recurs, has a good marked solution, and…
-
How to research a compound with no human data without deceiving yourself Replied, post #88 · Compounds › Other compounds · 3 Aug 2025 · 0 likes Worth separating two things that post #84 runs together. Compounds this community declines to help with, and why: there are specifics in the guidelines and they are not…
-
How to research a compound with no human data without deceiving yourself Replied, post #63 · Compounds › Other compounds · 2 Aug 2025 · 1 like Picking up post #60: that is the part I would want checked first. Distinguishing marketed research compounds from true chemical synthesis: some online suppliers sell…
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #8 · Practice › Storage & stability · 28 Jul 2025 · 8 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #44 · Compounds › Cagrilintide & amylin analogues · 10 Jul 2025 · 22 likes Amylin signalling is distinct from GLP-1 signalling. Amylin slows gastric emptying and promotes satiety through a different receptor and different neural pathways. The…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #4 · Analytics › COA interpretation · 6 Jul 2025 · 10 likes This follows post #3 rather than contradicting it. When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #81 · Compounds › Tirzepatide · 3 Jul 2025 · 4 likes Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect to see charge states mostly in the 2+ to 4+ range, the same as…
-
Antibiotics and a course of something with delayed emptying Replied, post #71 · Practice › Interactions · 22 Jun 2025 · 17 likes post #70 answers the question as asked. The question underneath it is different. Supplements and herbs: many have no established interaction. Some do. If you are taking…
-
Distinguishing a deletion sequence by mass alone — the long version Replied, post #27 · Analytics › Mass spectrometry · 16 Jun 2025 · 19 likes What mass accuracy establishes: the measured mass is consistent with a specific composition. What it does not establish: purity, sequence order, stereochemistry, or the…
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #26 · Analytics › Home & field testing · 13 Jun 2025 · 0 likes I read post #24 twice before replying, because I had assumed the opposite. Lateral-flow devices: like a rapid COVID test. They have a reagent strip and produce a colour…
-
Meeting a protein target on a suppressed appetite Replied, post #3 · Nutrition & Training › Protein & intake · 31 May 2025 · 0 likes Meeting protein targets on suppressed appetite: this is where the practical difficulty lies. Eating more protein when appetite is suppressed is genuinely hard.…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #62 · Compounds › Tirzepatide · 29 May 2025 · 32 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Washout: how long is long enough, and for what purpose Replied, post #29 · Pharmacology › Pharmacokinetics · 24 May 2025 · 16 likes Coming back to post #27, because the follow-up matters more than the original answer. Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days.…
-
Half-life, steady state, and accumulation worked through Replied, post #4 · Pharmacology › Pharmacokinetics · 19 May 2025 · 0 likes This follows post #3 rather than contradicting it. Individual variation: people vary in how quickly they absorb, distribute, metabolise, and excrete these compounds.…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #99 · Sourcing › Independent verification · 15 May 2025 · 24 likes Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks by mail; VendorInvestigate documentation review is…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #79 · Practice › Interactions · 9 May 2025 · 0 likes Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #2 · Outcomes › Body composition · 3 May 2025 · 0 likes Maintenance phase: tracking body composition during maintenance (weight stable) is different from tracking during active loss. Changes are smaller and precision becomes…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #105 · Evidence › Journal club · 27 Apr 2025 · 1 like Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Reading order for a first week here, and what to skip until later Replied, post #92 · Start Here › Welcome · 20 Apr 2025 · 0 likes On post #88 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
Adjudicated events and why the definition matters — the long version Replied, post #107 · Evidence › Trials · 19 Apr 2025 · 17 likes Surrogate endpoints: an endpoint that is not the outcome that matters but is measured as a stand-in. HbA1c is a surrogate for long-term glucose control and the…
-
Documenting a supplier's response to a discrepancy — does this still hold? Replied, post #51 · Sourcing › Vendor reports · 3 Apr 2025 · 26 likes post #50 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #71 · Compounds › Cagrilintide & amylin analogues · 31 Mar 2025 · 1 like Picking up post #68: that is the part I would want checked first. Reading the phase 2 paper: it establishes tolerability and efficacy in a selected population on a…
-
Review cadence: how often is a page actually re-checked? Replied, post #2 · Documentation › Doc review · 28 Mar 2025 · 13 likes I read the opening post twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want…
-
Follow-up: Journal club: the retatrutide phase 2 obesity paper Replied, post #6 · Evidence › Journal club · 19 Mar 2025 · 1 like I read post #4 twice before replying, because I had assumed the opposite. PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy.…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #83 · Analytics › COA interpretation · 15 Mar 2025 · 31 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Reading an MS report that only gives you a single number Replied, post #13 · Analytics › Mass spectrometry · 18 Feb 2025 · 0 likes Tandem mass spectrometry: MS/MS fragments the molecular ion and uses fragment masses to confirm identity and detect modifications. A simple identity confirmation by…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #98 · Compounds › Semaglutide · 2 Feb 2025 · 22 likes The SELECT trial changed the positioning because it was the first cardiovascular outcome trial in people without diabetes. That decoupled the cardiovascular argument…
-
Specification in the result column: why that is a meaningful error — the long version Replied, post #8 · Analytics › COA interpretation · 14 Jan 2025 · 4 likes Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If…
-
Gallbladder disease risk with rapid weight loss Replied, post #54 · Clinical › Comorbidities · 7 Jan 2025 · 0 likes post #53 is right about the mechanism and I think understates the practical bit. Multiple comorbidities: a person with diabetes, kidney disease, and cardiovascular…
-
A page that has drifted out of date and needs a maintainer Replied, post #44 · Documentation › Wiki requests · 26 Dec 2024 · 11 likes Accessibility feedback: if you have trouble accessing or reading a maintained page (screen reader issues, contrast problems, small text) report it. Accessibility matters.
-
What we do not know about retatrutide, listed explicitly Replied, post #28 · Compounds › Retatrutide · 21 Dec 2024 · 0 likes post #27 is right about the mechanism and I think understates the practical bit. Why this subcategory is more cautious than elsewhere: retatrutide is investigational,…
-
Building a sensible monitoring schedule with your prescriber Replied, post #53 · Clinical › Bloodwork · 20 Dec 2024 · 0 likes Analytical imprecision: any measurement has an error margin. A small difference in consecutive tests is usually measurement noise, not a real change. Knowing the…
-
Checking someone else's arithmetic: a worked example thread Replied, post #3 · Practice › Reconstitution · 20 Nov 2024 · 13 likes Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at that concentration, 100 units = 1 mL = 2.5 mg, so…
-
Coming back to: Research-use-only labelling: what it means and what it does not Replied, post #29 · Sourcing › Regulatory · 15 Nov 2024 · 17 likes Regulatory positions change: a compound's status today might differ from its status a year from now. Citing a regulatory position is worth doing only with a date…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #51 · Compounds › Repair & healing peptides · 14 Nov 2024 · 16 likes Publication patterns in the BPC-157 literature: a large proportion of the evidence comes from one research group. That is not necessarily wrong — one group can do…
-
Revisiting: Moderation log format change Replied, post #6 · Meta › Announcements · 24 Oct 2024 · 16 likes Scheduled maintenance: if the site is going offline for maintenance, advance notice will be posted here with the duration and scope.
-
Correlation in a self-tracked dataset: what it can support Replied, post #53 · Research Methods › Statistics · 22 Aug 2024 · 8 likes post #52 answers the question as asked. The question underneath it is different. Power and sample size: a study might be too small to detect a real effect (low power).…
-
Cold packs, phase-change material, and what survives ten days Replied, post #130 · Sourcing › Logistics · 21 Jul 2024 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…